LB
CLVS

Leo Brokerage’s Clovis Oncology, Inc. CLVS Stock Holding History

Leo Brokerage’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$107K Hold
23,940
– – 0.02% 180
2021
Q2 		$139K Hold
23,940
– – 0.03% 186
2021
Q1 		$168K Hold
23,940
– – 0.05% 174
2020
Q4 		$115K Hold
23,940
– – 0.04% 170
2020
Q3 		$162K Buy
+23,940
New +$143K 0.07% 118

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Leo Brokerage's CLVS Position: Q3 2021 in Review

Leo Brokerage held its Clovis Oncology, Inc. (CLVS) position steady in Q3 2021 at 23,940 shares worth $107K. The position accounts for 0.02% of the portfolio, ranked #180.

Leo Brokerage first reported a position in CLVS in Q3 2020 and has held it in 5 quarters since. The position peaked at $168K in Q1 2021. 157 funds tracked by Wall St. Rank hold CLVS as of Q3 2021.

  • Leo Brokerage held 23,940 shares of Clovis Oncology, Inc. worth $107K as of Q3 2021.
  • Leo Brokerage left its Clovis Oncology, Inc. share count unchanged in Q3 2021.
  • Clovis Oncology, Inc. made up 0.02% of Leo Brokerage's portfolio in Q3 2021, its #180 holding.
  • Leo Brokerage first reported a position in Clovis Oncology, Inc. in Q3 2020 and has held it in 5 quarters since.
  • Leo Brokerage's Clovis Oncology, Inc. position peaked at $168K in Q1 2021.
  • 157 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2021.

Based on Leo Brokerage's 13F filing for Q3 2021, filed 13 Oct 2021.